Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 5/2013

01.05.2013 | Article

Selective reporting of antibiotic susceptibility data improves the appropriateness of intended antibiotic prescriptions in urinary tract infections: a case-vignette randomised study

verfasst von: C. Coupat, C. Pradier, N. Degand, P. Hofliger, C. Pulcini

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this investigation was to assess the impact of selective reporting of antibiotic susceptibility data on the appropriateness of intended documented antibiotic prescriptions in urinary tract infections (UTIs) among residents training in general practice. We conducted a randomised-controlled case-vignette study in three French universities using a questionnaire with four UTI vignettes. In each university, residents were randomly allocated to two groups: a control group with usual full-length reporting of antibiotic susceptibility data (25 antibiotics) and an intervention group with selective reporting of antibiotic susceptibility data (2 to 4 antibiotics only). 326/611 residents (53 %) participated in the survey, 157/305 (52 %) in the intervention group and 169/306 (55 %) in the control group. For all four UTI scenarios, selective reporting of antibiotic susceptibility data significantly improved the appropriateness of antibiotic prescriptions (absolute increase ranging from 7 to 41 %, depending on the vignette). The variety of antibiotic prescriptions was reduced in the intervention group, and cephalosporins and fluoroquinolones were less often prescribed. Among 325 respondents, 124 (38 %) declared being either not really or not at all at ease with antibiotic susceptibility data, whereas 112/157 (71 %) of the residents in the intervention group declared that selective reporting of antibiotic susceptibility data made their antibiotic choice easier. Selective reporting of antibiotic susceptibility data could be a promising strategy to improve antibiotic use in UTIs, as part of a multi-faceted antibiotic stewardship programme. Microbiology laboratories should be aware that they can have a significant influence on antibiotic use.
Literatur
1.
Zurück zum Zitat MacKenzie FM, Gould IM, Bruce J, Mollison J, Monnet DL, Krcmery V, Cookson B, van der Meer JWM (2007) The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals. J Hosp Infect 65(Suppl 2):73–81. doi:10.1016/S0195-6701(07)60019-X PubMedCrossRef MacKenzie FM, Gould IM, Bruce J, Mollison J, Monnet DL, Krcmery V, Cookson B, van der Meer JWM (2007) The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals. J Hosp Infect 65(Suppl 2):73–81. doi:10.​1016/​S0195-6701(07)60019-X PubMedCrossRef
2.
Zurück zum Zitat Cunney R, Aziz HA, Schubert D, McNamara E, Smyth E (2000) Interpretative reporting and selective antimicrobial susceptibility release in non-critical microbiology results. J Antimicrob Chemother 45(5):705–708PubMedCrossRef Cunney R, Aziz HA, Schubert D, McNamara E, Smyth E (2000) Interpretative reporting and selective antimicrobial susceptibility release in non-critical microbiology results. J Antimicrob Chemother 45(5):705–708PubMedCrossRef
3.
Zurück zum Zitat Howell-Jones RS, Baker IB, McNulty CA; HPA GP Microbiology Laboratory Use Group (2008) Microbial investigation of venous leg ulcers. J Wound Care 17(8):353–358PubMed Howell-Jones RS, Baker IB, McNulty CA; HPA GP Microbiology Laboratory Use Group (2008) Microbial investigation of venous leg ulcers. J Wound Care 17(8):353–358PubMed
4.
Zurück zum Zitat Steffee CH, Morrell RM, Wasilauskas BL (1997) Clinical use of rifampicin during routine reporting of rifampicin susceptibilities: a lesson in selective reporting of antimicrobial susceptibility data. J Antimicrob Chemother 40(4):595–598PubMedCrossRef Steffee CH, Morrell RM, Wasilauskas BL (1997) Clinical use of rifampicin during routine reporting of rifampicin susceptibilities: a lesson in selective reporting of antimicrobial susceptibility data. J Antimicrob Chemother 40(4):595–598PubMedCrossRef
5.
Zurück zum Zitat Langdale P, Millar MR (1986) Influence of laboratory sensitivity reporting on antibiotic prescribing preferences of general practitioners in the Leeds area. J Clin Pathol 39(2):233–234PubMedCrossRef Langdale P, Millar MR (1986) Influence of laboratory sensitivity reporting on antibiotic prescribing preferences of general practitioners in the Leeds area. J Clin Pathol 39(2):233–234PubMedCrossRef
6.
Zurück zum Zitat Tan TY, McNulty C, Charlett A, Nessa N, Kelly C, Beswick T (2003) Laboratory antibiotic susceptibility reporting and antibiotic prescribing in general practice. J Antimicrob Chemother 51(2):379–384PubMedCrossRef Tan TY, McNulty C, Charlett A, Nessa N, Kelly C, Beswick T (2003) Laboratory antibiotic susceptibility reporting and antibiotic prescribing in general practice. J Antimicrob Chemother 51(2):379–384PubMedCrossRef
7.
Zurück zum Zitat McNulty CA, Lasseter GM, Charlett A, Lovering A, Howell-Jones R, Macgowan A, Thomas M (2011) Does laboratory antibiotic susceptibility reporting influence primary care prescribing in urinary tract infection and other infections? J Antimicrob Chemother 66(6):1396–1404. doi:10.1093/jac/dkr088 PubMedCrossRef McNulty CA, Lasseter GM, Charlett A, Lovering A, Howell-Jones R, Macgowan A, Thomas M (2011) Does laboratory antibiotic susceptibility reporting influence primary care prescribing in urinary tract infection and other infections? J Antimicrob Chemother 66(6):1396–1404. doi:10.​1093/​jac/​dkr088 PubMedCrossRef
8.
Zurück zum Zitat AFSSAPS (Agence française de sécurité sanitaire des produits de santé) (2008) AFSSAPS Practice recommendations for diagnosis and antibiotic therapy of adult community urinary tract infections. Med Mal Infect 38(Suppl 3):S203–S252 AFSSAPS (Agence française de sécurité sanitaire des produits de santé) (2008) AFSSAPS Practice recommendations for diagnosis and antibiotic therapy of adult community urinary tract infections. Med Mal Infect 38(Suppl 3):S203–S252
9.
Zurück zum Zitat Cunney RJ, Smyth EG (2000) The impact of laboratory reporting practice on antibiotic utilisation. Int J Antimicrob Agents 14(1):13–19PubMedCrossRef Cunney RJ, Smyth EG (2000) The impact of laboratory reporting practice on antibiotic utilisation. Int J Antimicrob Agents 14(1):13–19PubMedCrossRef
10.
Zurück zum Zitat Lucet JC, Nicolas-Chanoine MH, Lefort A, Roy C, Diamantis S, Papy E, Riveros-Palacios O, Le Grand J, Rioux C, Fantin B, Ravaud P (2011) Do case vignettes accurately reflect antibiotic prescription? Infect Control Hosp Epidemiol 32(10):1003–1009. doi:10.1086/661914 PubMedCrossRef Lucet JC, Nicolas-Chanoine MH, Lefort A, Roy C, Diamantis S, Papy E, Riveros-Palacios O, Le Grand J, Rioux C, Fantin B, Ravaud P (2011) Do case vignettes accurately reflect antibiotic prescription? Infect Control Hosp Epidemiol 32(10):1003–1009. doi:10.​1086/​661914 PubMedCrossRef
11.
Zurück zum Zitat Peabody JW, Luck J, Glassman P, Jain S, Hansen J, Spell M, Lee M (2004) Measuring the quality of physician practice by using clinical vignettes: a prospective validation study. Ann Intern Med 141(10):771–780PubMed Peabody JW, Luck J, Glassman P, Jain S, Hansen J, Spell M, Lee M (2004) Measuring the quality of physician practice by using clinical vignettes: a prospective validation study. Ann Intern Med 141(10):771–780PubMed
13.
Zurück zum Zitat Denes E, Prouzergue J, Ducroix-Roubertou S, Aupetit C, Weinbreck P (2012) Antibiotic prescription by general practitioners for urinary tract infections in outpatients. Eur J Clin Microbiol Infect Dis 31(11):3079–3083. doi:10.1007/s10096-012-1668-9 PubMedCrossRef Denes E, Prouzergue J, Ducroix-Roubertou S, Aupetit C, Weinbreck P (2012) Antibiotic prescription by general practitioners for urinary tract infections in outpatients. Eur J Clin Microbiol Infect Dis 31(11):3079–3083. doi:10.​1007/​s10096-012-1668-9 PubMedCrossRef
Metadaten
Titel
Selective reporting of antibiotic susceptibility data improves the appropriateness of intended antibiotic prescriptions in urinary tract infections: a case-vignette randomised study
verfasst von
C. Coupat
C. Pradier
N. Degand
P. Hofliger
C. Pulcini
Publikationsdatum
01.05.2013
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 5/2013
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1786-4

Weitere Artikel der Ausgabe 5/2013

European Journal of Clinical Microbiology & Infectious Diseases 5/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.